Please login to the form below

Not currently logged in
Email:
Password:

Novartis completes Alcon deal

Novartis has announced it has acquired 77 per cent majority ownership of Alcon, a Swiss medical company specialising in eye-care products

Novartis has announced it has completed a deal giving the company 77 per cent majority ownership of Alcon, a Swiss medical company specialising in eye-care products.

Novartis, also based in Switzerland, became the majority owner after finalising the acquisition of 52 per cent of Alcon shares from Nestlé for a total of $28.3bn. Novartis had previously acquired a 25 per cent stake in Alcon in July 2008.

"We are delighted to become majority owners of Alcon. Together, both companies can achieve their strategic priorities to deliver against patient needs through innovative and differentiated products" said Joe Jimenez, CEO of Novartis.

Alcon is the world's largest eye-care company, with 2009 sales of $6.5bn and a net income of $2.0bn.

As part of the deal, the US Federal Trade Commission (FTC) said Novartis must sell eye drug Miochol-E (acetylcholine chloride), an injectable eye care drug used in cataract surgery.

Plans for a complete takeover of Alcon were announced at the beginning of 2010 though the deal ran into problems when minority public shareholders voiced concerns that Novartis had offered two groups of Alcon shareholders two different prices for the same stock.

Novartis has said a direct merger of Alcon into Novartis is proposed under the Swiss Merger Act at a fixed exchange ratio of 2.8 Novartis shares for each remaining Alcon share in order to acquire the remaining 23 per cent of stock.

26th August 2010

Share

Related Hub content

    Your search did not contain any words. Please try again.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Saatchi & Saatchi Health

The conception of intelligent and creative belief-changing ideas is at the heart of everything we do, because experience has taught...

Latest intelligence

Getting to grips with Russia’s healthcare market
As a non-Russian, trying to understand the complexities of the multiple overlapping levels of Russia’s healthcare system can be baffling at times. Information is often inaccessible or data simply doesn't...
Online Physician Communities
Doctors.net.uk expands its online educational resources for doctors
Includes video for three procedures that all doctors are expected to be able to do...
Online Physician Communities
Review: diabetes tweetchat
Some of the key points from the recent #M3diabetes tweetchat held by PMLiVE and M3 Europe...